Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T17:58:00.557Z.
Calculation as of: 2026-10-06T17:58:00.557Z.
Quote observation: 2026-10-06T17:55:09.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 24a0b8a5defa6360a8df5348432e42fec2fdf5a1d44ff9a0d63a76d612d48360
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$1.11B
Free Cash Flow Yield
N/A
TTM Avg
0.41%
3Y Avg
1.18%
5Y Avg
0.87%
Market Cap
$1.11B
Free Cash Flow Yield
N/A
TTM Avg
2.12%
3Y Avg
1.83%
5Y Avg
1.83%
Market Cap
$1.11B
Free Cash Flow Yield
N/A
TTM Avg
1.42%
3Y Avg
0.92%
5Y Avg
0.70%
Market Cap
$1.10B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.13B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.13B
Free Cash Flow Yield
0.47%
TTM Avg
1.55%
3Y Avg
1.07%
5Y Avg
1.41%
Market Cap
$1.09B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.14B
Free Cash Flow Yield
12.80%
TTM Avg
11.24%
3Y Avg
6.85%
5Y Avg
5.53%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Replimune Group, Inc. (REPL) | $1.11B | N/A | N/A | N/A | N/A |
| Tandem Diabetes Care, Inc. (TNDM)vs › | $1.11B | N/A | 0.41% | 1.18% | 0.87% |
| OPKO Health, Inc. (OPK)vs › | $1.11B | N/A | 2.12% | 1.83% | 1.83% |
| STAAR Surgical Company (STAA)vs › | $1.11B | N/A | 1.42% | 0.92% | 0.70% |
| First Tracks Biotherapeutics Inc (TRAX)vs › | $1.10B | N/A | N/A | N/A | N/A |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | N/A | N/A | N/A | N/A |
| Harrow Health, Inc. (HROW)vs › | $1.13B | 0.47% | 1.55% | 1.07% | 1.41% |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | N/A | N/A | N/A | N/A |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.14B | 12.80% | 11.24% | 6.85% | 5.53% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.14B | 13.41% | 12.18% | 9.49% | 7.36% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
